Incidence and survival of peritoneal malignant mesothelioma between 1989 and 2015: A population-based study

Archive ouverte

Le Stang, Nolwenn | Bouvier, Véronique | Glehen, Olivier | Villeneuve, Laurent | Galateau-Sallé, Françoise | Clin, Bénédicte

Edité par CCSD ; Elsevier -

International audience. BACKGROUND:Peritoneal malignant mesothelioma is a rare disease for which few population-based studies are available. The aim of this study was to describe the evolution of the incidence and survival of peritoneal malignant mesothelioma in France between 1989 and 2015, using data derived from the French network of cancer registries.METHODS:Age world-standardized incidence rates and overall survival were calculated using data from 16 French cancer registries. Log-linear Poisson regression analysis was used to estimate the average annual percentage change in incidence rates. Overall survival was performed using age-adjusted Cox proportional hazards model.RESULTS:In French men, the incidence has increased quietly over the reporting period from 0.07 to 0.10 with a maximum of 0.16 per 100,000 persons-years in 2001-2003. For women, the increase in incidence has been lower than for men over the period 1989-2015, ranging from 0.04 to 0.11. A better prognosis was associated with a diagnosis made after 2000 (HR = 1.76; p = 0.013), the epithelioid histological type (p = 0.003), and the fact of being a woman, which has a 5-year risk of death half that of men (HR = 0.55; p = 0.001), regardless of age, diagnosis period or histology.CONCLUSION:Our results are similar to those currently available for other countries. In France, peritoneal mesothelioma remains a rare and fatal cancer with a small increase in the incidence rate since 1989 and a median survival of 1 year; it seemed to develop equally in women and men over this period of time.

Suggestions

Du même auteur

Study of mesothelioma associated factors in women. Etude des facteurs associés au mésothéliome chez la femme

Archive ouverte | Le Stang, Nolwenn | CCSD

Mesothelioma is a rare malignant serous tumor with a poor prognosis of which asbestos exposure is the major known risk factor. It occurs with a latent period about 30 years after exposure, reaches mainly the pleura and affects mai...

Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group

Archive ouverte | Levallet, Guenaelle | CCSD

International audience

Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis

Archive ouverte | Alkurdi, Lugain | CCSD

IF 5.638 (2-year impact factor). International audience. Toll-like receptor 3 (TLR3) mediates innate immune responses by sensing viral dsRNA, but also induces apoptosis selectively in cancer cells. Our analysis by i...

Chargement des enrichissements...